ITMCTR2200006070尚未招募未知
Clinical study on improving the activity endurance of Gubenquyujiedu formula in patients with chronic obstructive pulmonary disease
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 20 至 80（—）
- 性别
- All
入选标准
- •(1) Patients with AECOPD with grade I or II disease.
- •(2) Patients with TCM evidence of stasis and toxin blockage.
- •(3) The number of acute exacerbations of COPD in the past two years > 1 time/year.
- •(4) 20 years old = age = 80 years old.
- •(5) Voluntarily accept the treatment and sign the informed consent form.
排除标准
- •(1) Patients with combined asthma, impaired consciousness, pneumonia, tuberculosis, pleural effusion, malignancy and hematological disorders.
- •(2) Patients with severe impairment of cardiac, hepatic and renal functions (cardiac function grade 3-4, ALT and/or AST more than 1.5 times the upper limit of normal, Cr more than the upper limit of normal).
- •(3) Suffering from mental illness, cardiovascular and cerebrovascular thrombotic diseases.
- •(4) Persons with congenital or acquired immunodeficiency.
- •(5) Those with known allergy to therapeutic drugs.
研究者
相似试验
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444.EUCTR2010-023444-32-DKGlaxoSmithKline341
进行中（未招募）
不适用
A study to evaluate lung treatment and exercise tolerance of COPD patients with a new bronchodilator: GSK573719/GW642444EUCTR2010-023442-75-EEGlaxoSmithKline341
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444 - N/AEUCTR2010-023442-75-DEGlaxoSmithKline341
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444. - n/aChronic Obstructive Pulmonary Disease (COPD)MedDRA version: 13.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-023444-32-GBGlaxoSmithKline341
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444.EUCTR2010-023444-32-CZGlaxoSmithKline341